FIELD: medicine, prophylaxis. SUBSTANCE: method is achieved by increased kinetic energy of inhaled airflow due to its complete braking at respiratory system inhalation at initial phase of inhalation and restart of movement at achieving necessary level of intrapleural discharging. At the same time airflow saturation by medicinal substance is conducted simultaneously with resumption of airflow movement at its maximal kinetic energy, in mouth cavity airflow should be directed towards desirable place of medicinal substance precipitation to localize the action of the latter. EFFECT: increased penetrating mass and width of penetration of medicinal substance into respiratory system. 3 cl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
SMOKING PIPE-TYPE INHALER | 1991 |
|
RU2012361C1 |
SINGLE DOSE DRY POWDER INHALER | 2015 |
|
RU2610779C1 |
INHALER | 2021 |
|
RU2748203C1 |
DEVICE FOR DRUG DELIVERY FOR TREATMENT OF PATIENTS WITH DISEASES OF BREATHING ORGANS | 2013 |
|
RU2648849C2 |
INTRODUCTION OF ILOPROST IN FORM OF AEROSOL BOLUSES | 2012 |
|
RU2605849C2 |
MEDICINAL AGENT | 1994 |
|
RU2093171C1 |
DRY POWDER DRUG DELIVERY SYSTEMS AND METHODS | 2013 |
|
RU2650035C2 |
SYSTEMS AND METHODS FOR DRY POWDER DRUG DELIVERY | 2011 |
|
RU2571331C1 |
SYSTEMS AND METHODS FOR DRY POWDER DRUGS DELIVERY | 2011 |
|
RU2531455C2 |
METHOD FOR HEALTH STABILISATION | 2012 |
|
RU2526266C2 |
Authors
Dates
1998-02-10—Published
1991-11-13—Filed